Letter by Machado-Alba et al Regarding Article, “Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis” [Letter to the Editor]
Source: Stroke - Category: Neurology Authors: Jorge Enrique Machado–Alba, Daniel Ricardo Arias–Jaramillo, Andres Gaviria–Mendoza Tags: Epidemiology, Primary Prevention, Risk Factors, Secondary Prevention Letters to the Editor Source Type: research
More News: Atrial Fibrillation | Coumadin | Epidemiology | Men | Pradaxa | Stroke | Study | Warfarin